NASDAQ:DTIL Precision BioSciences (DTIL) Stock Price, News & Analysis $6.33 -0.03 (-0.47%) Closing price 09/24/2026 04:00 PM EasternExtended Trading$6.35 +0.02 (+0.30%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOwnershipSEC FilingsShort Interest About Precision BioSciences Stock (NASDAQ:DTIL) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Precision BioSciences alerts:Sign Up Key Stats Today's Range$6.18▼$6.4750-Day Range$6.33▼$8.8552-Week Range$3.53▼$9.62Volume401,824 shsAverage Volume236,222 shsMarket Capitalization$174.71 millionP/E RatioN/ADividend YieldN/APrice Target$32.25Consensus RatingModerate Buy Company Overview Precision BioSciences, Inc. is a biotechnology company developing gene-editing medicines for genetically driven diseases. The company’s platform, ARCUS, uses engineered homing endonucleases designed to make precise changes to DNA, including targeted gene insertion, deletion and correction. Precision’s pipeline has included in vivo gene-editing programs intended to address conditions such as Duchenne muscular dystrophy and chronic hepatitis B. The company has also developed allogeneic CAR T-cell candidates and has pursued collaborations and licensing arrangements to advance its gene-editing technology across therapeutic applications. Founded in 2006 and headquartered in Durham, North Carolina, Precision BioSciences conducts research and clinical development through operations and partnerships that support the development of genetic medicines in the United States and internationally.AI Generated. May Contain Errors. Read More Precision BioSciences Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks47th Percentile Overall ScoreDTIL MarketRank™: Precision BioSciences scored higher than 47% of companies evaluated by MarketBeat, and ranked 594th out of 901 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.7 / 5Analyst RatingModerate Buy Consensus RatingPrecision BioSciences has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on no strong buy ratings, 4 buy ratings, no hold ratings, and 1 sell rating.Upside PotentialPrecision BioSciences has a consensus price target of $32.25, representing about 409.5% upside from its current price of $6.33.Amount of Analyst CoveragePrecision BioSciences has only been the subject of 2 research reports in the past 90 days.Read more about Precision BioSciences' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Precision BioSciences are expected to grow in the coming year, from ($3.33) to ($1.86) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Precision BioSciences is -2.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Precision BioSciences is -2.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioPrecision BioSciences has a P/B Ratio of 1.57. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Precision BioSciences' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted8.28% of the float of Precision BioSciences has been sold short.Short Interest Ratio / Days to CoverPrecision BioSciences has a short interest ratio ("days to cover") of 10.55, which indicates bearish sentiment.Change versus previous monthShort interest in Precision BioSciences has recently decreased by 11.73%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldPrecision BioSciences does not currently pay a dividend.Dividend GrowthPrecision BioSciences does not have a long track record of dividend growth. News and Social Media2.0 / 5News Sentiment0.20 News SentimentPrecision BioSciences has a news sentiment score of 0.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.55 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Precision BioSciences this week, compared to 3 articles on an average week.Search InterestOnly 1 people have searched for DTIL on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat Follows3 people have added Precision BioSciences to their MarketBeat watchlist in the last 30 days. Company Ownership0.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Precision BioSciences insiders have not sold or bought any company stock.Percentage Held by Insiders2.70% of the stock of Precision BioSciences is held by insiders.Percentage Held by Institutions37.99% of the stock of Precision BioSciences is held by institutions.Read more about Precision BioSciences' insider trading history. Receive DTIL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Precision BioSciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DTIL Stock News HeadlinesPrecision Biosciences Inc.September 23 at 10:48 PM | barrons.comContrasting Yarrow Bioscience (NASDAQ:YARW) & Precision BioSciences (NASDAQ:DTIL)September 18, 2026 | americanbankingnews.comSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely. | Altimetry (Ad)Precision BioSciences Commences Dosing in Phase 1/2 FUNCTION-DMD StudyAugust 24, 2026 | businesswire.comPrecision BioSciences: Promising HBV Editing EvidenceAugust 18, 2026 | seekingalpha.comPrecision BioSciences: Q2 Earnings SnapshotAugust 6, 2026 | chron.comPrecision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business UpdateAugust 6, 2026 | businesswire.comPrecision BioSciences to Report Second Quarter 2026 Financial Results on August 6, 2026July 31, 2026 | businesswire.comSee More Headlines DTIL Stock Analysis - Frequently Asked Questions How have DTIL shares performed this year? Precision BioSciences' stock was trading at $4.16 at the beginning of 2026. Since then, DTIL shares have increased by 52.2% and is now trading at $6.33. How were Precision BioSciences' earnings last quarter? Precision BioSciences, Inc. (NASDAQ:DTIL) announced its quarterly earnings data on Thursday, August, 6th. The company reported ($1.26) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.80) by $0.46. Precision BioSciences had a negative trailing twelve-month return on equity of 72.52% and a negative net margin of 96.73%. When did Precision BioSciences' stock split? Shares of Precision BioSciences reverse split before market open on Wednesday, February 14th 2024.The 1-30 reverse split was announced on Wednesday, February 14th 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, February 14th 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. When did Precision BioSciences IPO? Precision BioSciences (DTIL) raised $126 million in an initial public offering on Thursday, March 28th 2019. The company issued 7,900,000 shares at $15.00-$17.00 per share. J.P. Morgan, Goldman Sachs, Jefferies and Barclays acted as the underwriters for the IPO. Who are Precision BioSciences' major shareholders? Precision BioSciences' top institutional investors include Corient Private Wealth LP (0.89%), Squarepoint Ops LLC (0.50%), Bank of New York Mellon Corp (0.23%) and Engineers Gate Manager LP (0.08%). Insiders that own company stock include Michael Amoroso, John Alexander Kelly, J Jefferson Smith, Geno J Germano, Melinda Brown, Stanley Frankel, Dario Scimeca and Alan List. View institutional ownership trends. How do I buy shares of Precision BioSciences? Shares of DTIL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Precision BioSciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Precision BioSciences investors own include Editas Medicine (EDIT), Luminar Technologies (LAZR), CRISPR Therapeutics (CRSP), Enovix (ENVX), Nokia (NOK) and Ginkgo Bioworks (DNA). Company Calendar Last Earnings8/06/2026Today9/25/2026Next Earnings (Estimated)11/02/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (6m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 DTIL's financial health is in the Green zone, according to TradeSmith. DTIL has been in this zone for over 6 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:DTIL CIK1357874 Webwww.precisionbiosciences.com Phone(919) 314-5512FaxN/AEmployees67Year Founded2006Price Target and Rating Average Price Target for Precision BioSciences$32.25 High Price Target$60.00 Low Price Target$19.00 Potential Upside/Downside+409.5%Consensus RatingModerate Buy Rating Score (0-4)2.60 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($2.80) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$45.72 million Net Margins-96.73% Pretax Margin-119.00% Return on Equity-72.52% Return on Assets-32.25% Debt Debt-to-Equity Ratio0.50 Current Ratio12.82 Quick Ratio12.82 Sales & Book Value Annual Sales$34.26 million Price / Sales5.10 Cash FlowN/A Price / Cash FlowN/A Book Value$4.03 per share Price / Book1.57Miscellaneous Outstanding Shares27,600,000Free Float26,857,000Market Cap$174.71 million OptionableNo Data Beta1.24 Social Links 10 Best Stocks to Own - Fall 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the economic uncertainty rattling markets right now. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free Report This page (NASDAQ:DTIL) was last updated on 9/25/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precision BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Precision BioSciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DTIL Stock Alerts